|
FY2026
12 months to Mar 31, 2026
|
FY2025
12 months to Mar 31, 2025
|
FY2024
12 months to Mar 31, 2024
|
FY2023
12 months to Dec 31, 2022
|
FY2022
12 months to Dec 31, 2021
|
|
|---|---|---|---|---|---|
| Net sales | |||||
| Cost of sales | |||||
| Gross profit | |||||
| Operating expenses: | |||||
| General and administrative | |||||
| Stock based compensation | |||||
| Marketing and selling | |||||
| Research and development | |||||
| Total operating expenses | |||||
| Loss from operations | |||||
| Other income | |||||
| Interest expense | |||||
| Other expenses | |||||
| Loss on extinguishment of debt | |||||
| (Gain) loss on foreign currency transactions | |||||
| Total other (income) expenses | |||||
| Loss before income taxes | |||||
| Income tax (expense) benefit | |||||
| Net loss | |||||
| Net income (loss) income attributable to non-controlling interests | |||||
| Net loss attributable to ZRCN Inc. common stockholders | |||||
| Income (loss) on change in foreign currency translation adjustment | |||||
| Comprehensive loss | |||||
| Other comprehensive income (loss) attributable to non-controlling interest | |||||
| Comprehensive loss attributable to ZRCN common stockholders | |||||
| Net loss per share attributable to ZRCN Inc.: | |||||
| Basic | |||||
| Diluted | |||||
| Weighted average common shares outstanding: | |||||
| Basic | |||||
| Diluted | |||||
Loading...